Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.

Literature DB >> 23517805

Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.

J Martin Brown, David J Brenner, David J Carlson.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 23517805 PMCID： PMC3608927 DOI： 10.1016/j.ijrobp.2012.11.003

Source DB: PubMed Journal: Int J Radiat Oncol Biol Phys ISSN： 0360-3016 Impact factor: 7.038

× No keyword cloud information.

12 in total

1. High-dose single-fraction radiotherapy: exploiting a new biology?

Authors: J Martin Brown; Albert C Koong
Journal: Int J Radiat Oncol Biol Phys Date: 2008-06-01 Impact factor: 7.038

Review 2. The linear-quadratic formula and progress in fractionated radiotherapy.

Authors: J F Fowler
Journal: Br J Radiol Date: 1989-08 Impact factor: 3.039

3. Immunologic correlates of the abscopal effect in a patient with melanoma.

Authors: Michael A Postow; Margaret K Callahan; Christopher A Barker; Yoshiya Yamada; Jianda Yuan; Shigehisa Kitano; Zhenyu Mu; Teresa Rasalan; Matthew Adamow; Erika Ritter; Christine Sedrak; Achim A Jungbluth; Ramon Chua; Arvin S Yang; Ruth-Ann Roman; Samuel Rosner; Brenna Benson; James P Allison; Alexander M Lesokhin; Sacha Gnjatic; Jedd D Wolchok
Journal: N Engl J Med Date: 2012-03-08 Impact factor: 91.245

4. Engaging the vascular component of the tumor response.

Authors: Zvi Fuks; Richard Kolesnick
Journal: Cancer Cell Date: 2005-08 Impact factor: 31.743

Review 5. Stereotactic body radiation therapy: a novel treatment modality.

Authors: Simon S Lo; Achilles J Fakiris; Eric L Chang; Nina A Mayr; Jian Z Wang; Lech Papiez; Bin S Teh; Ronald C McGarry; Higinia R Cardenes; Robert D Timmerman
Journal: Nat Rev Clin Oncol Date: 2009-12-08 Impact factor: 66.675

6. Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.

Authors: Niraj Mehta; Christopher R King; Nzhde Agazaryan; Michael Steinberg; Amanda Hua; Percy Lee
Journal: Pract Radiat Oncol Date: 2011-12-03

7. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.

Authors: Nitin Ohri; Maria Werner-Wasik; Inga S Grills; José Belderbos; Andrew Hope; Di Yan; Larry L Kestin; Matthias Guckenberger; Jan-Jakob Sonke; Jean-Pierre Bissonnette; Ying Xiao
Journal: Int J Radiat Oncol Biol Phys Date: 2012-11-01 Impact factor: 7.038

Review 8. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).

Authors: Heon Joo Park; Robert J Griffin; Susanta Hui; Seymour H Levitt; Chang W Song
Journal: Radiat Res Date: 2012-01-09 Impact factor: 2.841

9. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.

Authors: Amit A Lugade; James P Moran; Scott A Gerber; Robert C Rose; John G Frelinger; Edith M Lord
Journal: J Immunol Date: 2005-06-15 Impact factor: 5.422

10. Tumor response to radiotherapy regulated by endothelial cell apoptosis.

Authors: Monica Garcia-Barros; Francois Paris; Carlos Cordon-Cardo; David Lyden; Shahin Rafii; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick
Journal: Science Date: 2003-05-16 Impact factor: 47.728

31 in total

1. Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

Authors: Chang W Song; Yoon-Jin Lee; Robert J Griffin; Inhwan Park; Nathan A Koonce; Susanta Hui; Mi-Sook Kim; Kathryn E Dusenbery; Paul W Sperduto; L Chinsoo Cho
Journal: Int J Radiat Oncol Biol Phys Date: 2015-05-16 Impact factor: 7.038

Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.

1. High-dose single-fraction radiotherapy: exploiting a new biology?

Review 2. The linear-quadratic formula and progress in fractionated radiotherapy.

3. Immunologic correlates of the abscopal effect in a patient with melanoma.

4. Engaging the vascular component of the tumor response.

Review 5. Stereotactic body radiation therapy: a novel treatment modality.

6. Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent dose and local control.

7. Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group.

Review 8. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS).

9. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.

10. Tumor response to radiotherapy regulated by endothelial cell apoptosis.

1. Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

Review 2. New challenges in high-energy particle radiobiology.

Review 3. DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives.

Review 4. Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Review 5. Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy.

Review 6. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?

7. Dose escalation in the definite target volume.

Review 8. Indirect cell death and the LQ model in SBRT and SRS.

Review 9. Opportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) Era.

Review 10. Radiobiological basis of SBRT and SRS.